Benzinga | Jan 11, 2022 08:07AM EST

electroCore Announces Launch Of e-Commerce Shop

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine company, today announced the launch of an e-commerce shop for patients residing in the United States. The site, which can be accessed through www.gammacore.com, allows patients to complete a telehealth consult for a prescription and purchase gammaCore Sapphire(tm), a non-invasive vagus nerve stimulator (nVNS) device, online.



The online store offers therapy to patients for FDA-cleared indications like migraine and cluster headache. The store platform is powered by Vytal, LLC and allows patients to obtain a prescription via telehealth consult, purchase the therapy directly from the site, have a member of the U.S. electroCore customer service team provide post-purchase video conference training, and receive the device at their doorstep.

"The launch of an online store is a tremendous step forward in our company's cash pay, direct-to-consumer strategy," stated Joshua Lev, Chief Strategy Officer at electroCore. "More and more patients are utilizing online channels to manage their health, and the launch of our new online store builds on the trend of patients taking control of their healthcare. We are very excited to offer patients the ability to obtain nVNS therapy from the comfort of their home. The new functionality provides direct access to millions of migraine and cluster headache sufferers who can benefit from gammaCore nVNS therapy."

"We are thrilled to be a part of electroCore's direct-to-consumer initiative to treat migraines and cluster headaches. Our end-to-end solution for patient access to gammaCore allows a seamless patient experience that should help patients access this unique, proven therapy," said Jerry Gross, Founder and CEO of Vytal.